Develops cell therapies for cancer treatment.
Jun 2026Revenue $8.97M/yrExpenses $46.1M/yr
No trendCash runway ≈ 3 months from Jun 2026
Figures by year
When will Instil Bio be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $8.97M and expenses $46.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.97M | $87.5M | −$78.6M |
| Dec 2024 | $4.27M | $77.8M | −$73.5M |
| Dec 2023 | $0.00 | $159M | −$159M |
| Dec 2021 | $0.00 | $156M | −$156M |
| Dec 2020 | $138K | $33.8M | −$33.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.